Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial.
Charles V PollackFarideh DavoudiDeborah B DiercksRichard C BeckerStefan K JamesSoo Teik LimPhillip J SchulteJindrich SpinarPhilippe Gabriel StegRobert F StoreyAnders HimmelmannLars WallentinChristopher P Cannonnull nullPublished in: Clinical cardiology (2017)
The benefit of ticagrelor over clopidogrel was consistent in those undergoing early and late angiography, supporting upstream use of ticagrelor.
Keyphrases